📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting SWI/SNF mutant cancers with tyrosine kinase inhibitor therapy (2016)

First Author: Huang P

Attributed to: A toolkit for tyrosine kinase signalling network analysis. funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/14737140.2017.1257941

PubMed Identifier: 27819171

Publication URI: http://europepmc.org/abstract/MED/27819171

Type: Journal Article/Review

Parent Publication: Expert Review of Anticancer Therapy

Issue: 1

ISSN: 1473-7140